tbuckley/cabot-search huggingface dataset:
42405 A Photoaging Smartphone App to Promote Sun Safety in Young Children
Authors: Nicole Natarelli, Jaclyn Abraham, Grace Wei, Kerry Hennessy, Sarah Moore, Constance Bindernagel, Sharon Dabrow, Lana Soylu, Titus Brinker, Lucia Seminario-Vidal, Sharon Albers
Journal: Journal of the American Academy of Dermatology (2023)
42895 Validation of the skin pain numeric rating scale (NRS) in prurigo nodularis (PN) based on clinical studies of dupilumab in adults with PN
Authors: Donia Bahloul, Ryan B. Thomas, Stephanie Rhoten, Samantha Wratten, Sonja Ständer, Brian S. Kim, John T. O’Malley, Ashish Bansal, Jerome Msihid
Journal: Journal of the American Academy of Dermatology (2023)
44448 Rapid and Sustained Improvements with CBP-201 Across All Body Regions: Treatment of Atopic Dermatitis in a Phase 2b, Randomized, Double-blind, Placebo-controlled Trial (CBP-201-WW001)
Authors: Jonathan Silverberg, Malinda Longphre, Jang Yun, Wei Zheng, Chin Lee, Raul Collazo
Journal: Journal of the American Academy of Dermatology (2023)
40499 Psycho-cognitive Aspects of Disease Correlate Stronger with Quality of Life Impairment Compared to Objective Disease Severity
Authors: Ellie Choi, Valencia Long, Zhao Jin Chen, Yik Weng Yew, Steven Thng, Hazel Oon, Nisha Chandran, Chris Tan, Phillip Phan
Journal: Journal of the American Academy of Dermatology (2023)
Clinico-Genomic Profiling of Conventional and Dedifferentiated Chondrosarcomas Reveals <i>TP53</i> Mutation to Be Associated with Worse Outcomes
Authors: Ryan A. Denu, Richard K. Yang, Alexander J. Lazar, Shalin S. Patel, Valerae O. Lewis, Jason Roszik, J. Andrew Livingston, Wei-Lien Wang, Kenna R. Shaw, Ravin Ratan, Maria A. Zarzour, Justin Bird, Shaan Raza, Kadir C. Akdemir, Jordi Rodon Ahnert, Vivek Subbiah, Shreyaskumar Patel, Anthony P. Conley
Journal: Clinical Cancer Research (2023)

Abstract Purpose: Chondrosarcomas are the most common primary bone tumor in adults. Isocitrate dehydrogenase 1 (IDH1) and IDH2 mutations are prevalent. We aimed to assess the clinico-genomic properties of IDH mutant versus IDH wild-type (WT) chondrosarcomas as well as alterations in other genes. Experimental Design: We included 93 patients with conventional and dedifferentiated chondrosarcoma for which there were available clinical next-generation sequencing data. Clinical and genomic data were extracted and compared between IDH mutant and IDH WT chondrosarcomas and between TP53 mutant and TP53 WT chondrosarcomas. Results: IDH1 and IDH2 mutations are prevalent in chondrosarcoma (50.5%), more common in chondrosarcomas arising in the extremities, associated with higher age at diagnosis, and more common in dedifferentiated chondrosarcomas compared with grades 1–3 conventional chondrosarcoma. There was no difference in survival based on IDH mutation in univariate and multivariate analyses. TP53 mutation was the next most prevalent (41.9%) and is associated with worse overall survival and metastasis-free survival in both univariate and multivariate analyses. TP53 mutation was also associated with higher risk of recurrence following curative-intent surgery and worse survival among patients that presented with de novo metastatic disease. Conclusions: IDH mutations are prevalent in chondrosarcoma though were not associated with survival outcomes in this cohort. TP53 mutations were the next most common alteration and were associated with worse outcomes.
41658 Real-World Eﬀectiveness of Dupilumab in Adult and Adolescent Patients With Atopic Dermatitis: 2-Year Data From the PROSE Registry
Authors: Eric L. Simpson, Benjamin Lockshin, Lara Wine Lee, Zhen Chen, Moataz Daoud, Andrew Korotzer
Journal: Journal of the American Academy of Dermatology (2023)
42005 Sustained scalp, eyebrow, and eyelash hair regrowth with ritlecitinib through Week 48 in patients with alopecia areata: post hoc analysis of the ALLEGRO phase 2b/3 study
Authors: Melissa Piliang, Charles Lynde, Brett King, Paradi Mirmirani, Rodney Sinclair, Robert Wolk, Samuel Zwillich, Helen Tran, Fan Zhang, Liza Takiya
Journal: Journal of the American Academy of Dermatology (2023)
42087 Safety of Berdazimer Gel 10.3% in the Treatment of Molluscum Contagiosum: Integrated Results from the B-SIMPLE Phase 3 Program
Authors: John Browning, Adelaide Hebert, Amy Paller, Lawrence Green, Martina Cartwright, Carolyn Enloe, Nick Wells, Tomoko Maeda-Chubachi
Journal: Journal of the American Academy of Dermatology (2023)
42186 Prurigo nodularis blood signature is characterized by increases in IL-13 and caspase 8
Authors: Teresa Ju, Angelina Labib, Leigh Nattkemper, Sarah Engle, Autum Auxier, Nathan Hahn, Sean Sissons, Jonathan Sims, Zhe Sun, Angela Okragly, Gil Yosipovitch
Journal: Journal of the American Academy of Dermatology (2023)
44102 Risankizumab Efficacy for Moderate-to-Severe Plaque Psoriasis over 256 Weeks in Patients with Prior Biologic Treatments
Authors: Jeffrey Crowley, Chih-Ho Hong, Melinda Gooderham, Georgios Kokolakis, Huzefa Photowala, Simone Rubant, Tianyu Zhan, Andrew Blauvelt
Journal: Journal of the American Academy of Dermatology (2023)
42695 The future of biologics in dermatology: Low-dose rituximab
Authors: Mayra Alejandra Reyes-Soto, Luis Angel Yamallel, Alejandra Perales- González, Patrizia Elva Aguilar-Calderon, Valeria F. Garza-Dávila, David E. Kubelis-López, Alejandra Villarreal-Martinez, Jorge Ocampo-Candiani, Minerva Gomez-Flores, Sonia Chavez-Alvarez
Journal: Journal of the American Academy of Dermatology (2023)
42273 Phase 1 Study in Healthy Adults of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ALPN-303, a Dual BAFF/APRIL Antagonist for the Treatment of Autoimmune Blistering Diseases
Authors: Stacey R. Dillon, Rupert H. Davies, Jason D. Lickliter, Alina Smith, Mary C. Lessig, Lori Blanchfield, Russell J. Sanderson, Allison Chunyk, Amanda Enstrom, Hany Zayed, Stanford L. Peng
Journal: Journal of the American Academy of Dermatology (2023)
42407 Teledermatology in Practice: Report of Multi-site Experience During the COVID-19 Pandemic
Authors: Nessa Aghazadeh Mohandesi, Tudor Puiu, Matthew Hall, Olayemi Sokumbi, Aaron Mangold, Michael Colgan, Megha Tollefson, Julio Sartori Valinotti
Journal: Journal of the American Academy of Dermatology (2023)
43131 Population Pharmacokinetic and Pharmacodynamic Analyses of Cedirogant in Healthy Subjects and Subjects with Moderate to Severe Psoriasis
Authors: Corinna Maier, Doerthe Eckert, Stephen Laroux, Kinjal M. Hew, Ahmed Suleiman, Wei Liu, Mohamed-Eslam F. Mohamed
Journal: Journal of the American Academy of Dermatology (2023)
41625 Tapinarof Cream 1% Once Daily (QD) for Plaque Psoriasis: Post Hoc Analysis of Physician Global Assessment x Body Surface Area (PGAxBSA) Composite for the PSOARING 1 and 2 Trials
Authors: Bruce Strober, Leon Kircik, Lawrence Green, Benjamin Lockshin, Philip M. Brown, Anna M. Tallman
Journal: Journal of the American Academy of Dermatology (2023)
42899 Validation of the worst-itch numeric rating scale (WI-NRS) in prurigo nodularis (PN) based on clinical studies of dupilumab in adults with PN
Authors: Donia Bahloul, Ryan B. Thomas, Stephanie Rhoten, Isabelle Guillemin, Sonja Ständer, Brian S. Kim, John T. O’Malley, Ashish Bansal, Jerome Msihid
Journal: Journal of the American Academy of Dermatology (2023)
41947 Provider and Patient Perspectives on Self-Lancing of Hidradenitis Suppurativa (HS) Lesions
Authors: Claire Herzog, Lindsey Greenlund, Zachary Wendland, Marie-Claire Buckley, Joslyn Kirby, Afsaneh Alavi, Michelle Lowes, Noah Goldfarb
Journal: Journal of the American Academy of Dermatology (2023)
43792 Treatment Outcomes for up to 2 Years in Patients Aged Less Than 12 Years with Inadequately Controlled Moderate-to-Severe Atopic Dermatitis: Real-World Data From PEDISTAD
Authors: Amy S. Paller, Marjolein de Bruin-Weller, Danielle Marcoux, Eulalia Baselga, Vania Oliveira de Carvalho, Ledit R.F. Ardusso, Mirna Toledo-Bahena, Rajan Gupta, Marius Ardeleanu, Annie Zhang
Journal: Journal of the American Academy of Dermatology (2023)
42927 Unmet needs in treatment options and management strategies in hidradenitis suppurativa: understanding the patient perspective through social media listening
Authors: Christopher Sayed, Antonio Martorell, Ivette Alarcon, Torben Kasparek, Susan Frade, Barry M. McGrath, Bente Villumsen, Joslyn S. Kirby
Journal: Journal of the American Academy of Dermatology (2023)
42360 Side by Side Comparative Study: Moisturizer vs Moisturizer with Topical Tacrolimus in Atopic Dermatitis Patients
Authors: Yeon Joo Jung, Heeyeon Kim, Jai Hee Bae, Donghwi Jang, Joon Ho Shim, Se Jin Oh, Jong Hee Lee, Ji-Hye Park
Journal: Journal of the American Academy of Dermatology (2023)
44301 Patient Satisfaction and Outcomes within a Free Dermatology Clinic Implemented at Saint Louis University School of Medicine
Authors: Michael Kremer, Saniya Shaikh, Rylee Moody, Julia Hughes, Brooke Mccollum, Isra Taha, Eric Armbrecht, Nicole Burkemper, Sofia Chaudhry
Journal: Journal of the American Academy of Dermatology (2023)
43271 Patient-Reported Outcomes From the Randomized Phase 2b/3 PRISM Trial Evaluating Oral Nalbuphine Extended-Release Versus Placebo in Patients With Prurigo Nodularis
Authors: Sonja Ständer, Elke Weisshaar, Jennifer L. Parish, Jacek C. Szepietowski, Adam Reich, Neil J. Korman, Enoch Bortey, Thomas R. Sciascia
Journal: Journal of the American Academy of Dermatology (2023)
44248 Patient Reported Outcomes (PROs) assessed using Acne Symptom and Impact Scale (ASIS) among patients with moderate to severe non-nodular Acne Vulgaris (AV) administered sarecycline in community practices across the U.S: Race stratified analysis of PROSES
Authors: Andrew F. Alexis, Hilary Baldwin, Emmy Graber, Ismail Kasujee
Journal: Journal of the American Academy of Dermatology (2023)
Endothelial Notch1 signaling in white adipose tissue promotes cancer cachexia
Authors: Jacqueline Taylor, Leonie Uhl, Iris Moll, Sana Safatul Hasan, Lena Wiedmann, Jakob Morgenstern, Benedetto Daniele Giaimo, Tobias Friedrich, Elisenda Alsina-Sanchis, Francesca De Angelis Rigotti, Ronja Mülfarth, Sarah Kaltenbach, Darius Schenk, Felix Nickel, Thomas Fleming, David Sprinzak, Carolin Mogler, Thomas Korff, Adrian T. Billeter, Beat P. Müller-Stich, Mauricio Berriel Diaz, Tilman Borggrefe, Stephan Herzig, Maria Rohm, Juan Rodriguez-Vita, Andreas Fischer
Journal: Nature Cancer (2023)

Abstract Cachexia is a major cause of morbidity and mortality in individuals with cancer and is characterized by weight loss due to adipose and muscle tissue wasting. Hallmarks of white adipose tissue (WAT) remodeling, which often precedes weight loss, are impaired lipid storage, inflammation and eventually fibrosis. Tissue wasting occurs in response to tumor-secreted factors. Considering that the continuous endothelium in WAT is the first line of contact with circulating factors, we postulated whether the endothelium itself may orchestrate tissue remodeling. Here, we show using human and mouse cancer models that during precachexia, tumors overactivate Notch1 signaling in distant WAT endothelium. Sustained endothelial Notch1 signaling induces a WAT wasting phenotype in male mice through excessive retinoic acid production. Pharmacological blockade of retinoic acid signaling was sufficient to inhibit WAT wasting in a mouse cancer cachexia model. This demonstrates that cancer manipulates the endothelium at distant sites to mediate WAT wasting by altering angiocrine signals.
40890 No association between dupilumab use and cancer development in atopic dermatitis patients
Authors: Shayan Owji, Benjamin Ungar, Danielle Dubin, Dina Poplausky, Jade Young, Sabrina Ghalili, Joseph Han, Ana B. Pavel, Joel Correa da Rosa, Emma Guttman-Yassky, Nicholas Gulati
Journal: Journal of the American Academy of Dermatology (2023)
44080 No Difference in Time to First Melanoma Diagnosis Among Patients with Myasthenia Gravis, Grave’s Disease, or Hashimoto’s Thyroiditis: A Retrospective Matched Cohort Study
Authors: Benjamin Gorman, Elliott Campbell, Barbara Mullen, Neha Deo, Ji Won Ahn, Sama Carley, Austin Todd, Regina Castro, Nahid Vidal
Journal: Journal of the American Academy of Dermatology (2023)
43908 Overcoming Barriers to Specialty Care in Rural Georgia through Teledermatology
Authors: McKenzie Maloney, Marisol Miranda-Galvis, Brenda Santellano Juarez, Samah Ibrahim, Rhea-Beth Markowitz, Koosh Desai, Harold Rabinovitz, Kendall Buchanan, Douglas Patten, Loretta Davis, Jorge Cortes
Journal: Journal of the American Academy of Dermatology (2023)
43046 Outcomes of Down-Titration in Patients with Severe Scalp Alopecia Areata Treated with Baricitinib 4 Mg: Week 104 Data from BRAVE-AA2
Authors: Brett King, Manabu Ohyama, Maryanne Senna, Jerry Shapiro, Yves Dutronc, Wen-Shuo Wu, Guanglei Yu, Yuxin Ding, Chiara Chiasserini, Bianca Maria Piraccini
Journal: Journal of the American Academy of Dermatology (2023)
42364 MRPGRX2 Antagonist EP262 Prevents Inflammation and Disease in a Mouse Model of Atopic Dermatitis
Authors: Joshua Wollam, Michelle Solomon, Christiane Villescaz, Brittney Charlot, Jim Napora, Alan Vest, Christine Cavarlez, Lisa Dvorak, Andres Nevarez, Veena Viswanath, Marcus Boehm
Journal: Journal of the American Academy of Dermatology (2023)
43769 Molecular Correlation of Re-Pigmentation brought by Non-Cultured Epidermal Cell Suspension versus Hair Follicle Cell Suspension.
Authors: Niharika Srivastava, Anuradha Bishnoi, Vishal Thakur, Muthu Sendhil Kumaran, Keshavamurthy Vinay, Davinder Parsad
Journal: Journal of the American Academy of Dermatology (2023)
42275 Dupilumab Improves Itch, Skin Pain, and Sleep in Adult Patients With Prurigo Nodularis (LIBERTY PN-PRIME and PRIME2)
Authors: Shawn G. Kwatra, Gil Yosipovitch, Sonja Ständer, Isabelle Guillemin, Jérôme Msihid, Simmi Wiggins, Noah A. Levit, Ashish Bansal, John T. O’Malley, Donia Bahloul, B. Thomas
Journal: Journal of the American Academy of Dermatology (2023)
41817 Dupilumab Treatment Improves Sleep Quality in Children Aged 6 Months to 5 Years with Moderate-to-Severe Atopic Dermatitis and Their Caregivers
Authors: Amy S. Paller, Eric L. Simpson, Elaine C. Siegfried, Michael J. Cork, Andreas Wollenberg, Peter D. Arkwright, Amy Praestgaard, Randy Prescilla, Zhixiao Wang, Ainara Rodriguez Marco
Journal: Journal of the American Academy of Dermatology (2023)
42301 Efficacy and safety of clascoterone cream 1% in patients with acne vulgaris across subgroups defined by demographic characteristics
Authors: Lawrence F. Eichenfield, Adelaide A. Hebert, Diane Thiboutot, Linda Stein Gold, Martina Cartwright, Luigi Moro, Jenny Han, Nicholas Squittieri, Alessandro Mazzetti
Journal: Journal of the American Academy of Dermatology (2023)
42785 Distribution of cellular remnants of melanocytes in the nail plate: clue to diagnosis of subungual melanoma
Authors: Jai Hee Bae, Heeyeon Kim, Yeon Joo Jung, Donghwi Jang, Joon Ho Shim, Se Jin Oh, Ji Hye Park, Jong Hee Lee, Joo-Heung Lee, Dong-Youn Lee
Journal: Journal of the American Academy of Dermatology (2023)
Comprehensive mandatory policies are needed to fully protect all children from unhealthy food marketing
Authors: Francesca R. Dillman Carpentier, Fernanda Mediano Stoltze, Barry M. Popkin
Journal: PLoS Medicine (2023)

The World Health Organization (WHO) have released a new guideline, “ Policies to protect children from the harmful impact of food marketing” [1] which recommends the development of comprehensive laws to reduce children’s exposure to unhealthy food marketing. This new guideline extends previous recommendations [2] to limit the adverse effects of unhealthy food marketing on the health of the world’s children. We consider here whether these new recommendations go far enough.
41679 Lebrikizumab monotherapy improves quality of life through improvement in itch and sleep: Results from two Phase 3 trials in patients with moderate-to-severe atopic dermatitis
Authors: Gil Yosipovitch, Marjolein de Bruin-Weller, Marni Wiseman, Jesper Elberling, Jan Gutermuth, Evangeline Pierce, Sonia Montmayeur, Yuxin Ding, Emily Yang, Sarah Chisolm
Journal: Journal of the American Academy of Dermatology (2023)
43102 Efficacy of Sarecycline for Facial Acne Vulgaris in Patients With Skin of Color: Post Hoc Analysis of Phase 3 Trials
Authors: Jonette Keri, Julie Harper, Hilary Baldwin, Emmy Graber, Raidah Salem, Paul Tomondy, Francisco Hernandez, Andrew Alexis
Journal: Journal of the American Academy of Dermatology (2023)
42008 Long Term Hematologic Laboratory Safety of Dupilumab in Patients Aged 6 Months to 5 Years With Moderate-to-Severe Atopic Dermatitis
Authors: Elaine Siegfried, Michael J. Cork, Benjamin Lockshin, Mark Boguniewicz, Sumeet Uppal, Maria Vass, Faisal A. Khokhar, Ashish Bansal, Debra Sierka, Sonya Cyr
Journal: Journal of the American Academy of Dermatology (2023)
44094 Impact of Risankizumab on Nail Psoriasis and Enthesitis Among Psoriatic Arthritis Patients with High Nail Symptom Burden
Authors: Joseph F. Merola, Boni Elewski, Phoebe Rich, Ahmid Amin, Laura Savage, Kim Papp, Richard B. Warren, Megha Shah, Ahmed M. Soliman, Linyu Shi, Laura C. Coates
Journal: Journal of the American Academy of Dermatology (2023)
43880 Generation of a novel short-term assay to investigate intrinsic aging and to test candidate anti- aging actives in organ-cultured human skin ex vivo
Authors: Max van Lessen, Andrei Mardaryev, Christina Mauri, David Broadley, Marta Bertolini, Janin Edelkamp, Wolfgang Funk, Gerd Lindner, Oliver Schumacher, Tamas Bíró, Ralf Paus
Journal: Journal of the American Academy of Dermatology (2023)
42011 Dupilumab Improves Urticaria Signs and Symptoms and Quality of Life in Patients With Chronic Spontaneous Urticaria (CSU)
Authors: Marcus Maurer, Thomas B. Casale, Sarbjit S. Saini, Moshe Ben-Shoshan, Allen Radin, Deborah Bauer, Ryan B. Thomas, Leda P. Mannent, Aleksandra Stjepanovic
Journal: Journal of the American Academy of Dermatology (2023)
42014 Dupilumab Improves Disease-Specific Quality of Life in Patients With Prurigo Nodularis (LIBERTY-PN PRIME and PRIME2)
Authors: Shawn Kwatra, Gil Yosipovitch, Nicolas Mollanazar, Sonja Stander, Brian S. Kim, Jerome Msihid, Ashish Bansal, John T. O’Malley, Donia Bahloul, Ryan B. Thomas
Journal: Journal of the American Academy of Dermatology (2023)
42267 Improvements in Patient-Reported Outcomes Among Patients With Resolution of Enthesitis and/or Dactylitis: Post hoc Analyses From the KEEPsAKE 1 and 2 Trials of Risankizumab in Patients With Active Psoriatic Arthritis
Authors: Shawn G. Kwatra, Saakshi Khattri, Ahmad Z. Amin, Ran Liu, Byron Padilla, Ahmed M. Soliman, Blair Kaplan, Dennis McGonagle
Journal: Journal of the American Academy of Dermatology (2023)
41694 Evolution of Benzoyl Peroxide: Microencapsulated 5% Cream to Improve Tolerability in Papulopustular Rosacea
Authors: Hilary Baldwin, Boni Elewski, Ofra Levy-Hacham, Firas Hougier, Paul Yamauchi, Kate Hamil, Julie Harper
Journal: Journal of the American Academy of Dermatology (2023)
44255 Impact of acne on social functioning, emotional functioning, and activities of daily living(ADL) among patients with moderate to severe non-nodular Acne Vulgaris (AV) administered sarecycline in community practices across the U.S: Race stratified analysis
Authors: Andrew F. Alexis, Emmy Graber, Hilary Baldwin, Ismail Kasujee
Journal: Journal of the American Academy of Dermatology (2023)
41916 Lebrikizumab reduced interference of itch on sleep at 52 weeks in patients with moderate-to- severe atopic dermatitis: pooled analysis of two phase 3 randomized controlled trials
Authors: Gil Yosipovitch, Peter A. Lio, David Rosmarin, Franz J. Legat, Jose-Manuel Carrascosa, Eric Meskimen, Marta Casillas, Evangeline Pierce, Chenjia Xu, Jinglin Zhong
Journal: Journal of the American Academy of Dermatology (2023)
43251 Duration of acceptable delay until subsequent full body skin examination, given prior history of skin cancer or lesions suspicious for skin cancer
Authors: Michael D. Yi, Umer Nadir, Farhana Ikmal Hisham, Loma Dave, Ross Pearlman, Brandon Worley, Emily Poon, Rachel Christensen, Sarah Ibrahim, Bianca Kang, Murad Alam
Journal: Journal of the American Academy of Dermatology (2023)
43113 Ixekizumab improves fatigue, an important patient-reported outcome in psoriasis
Authors: Joseph Merola, Dafna Gladman, Hasan Tahir, Wolf-Henning Boehncke, Alyssa Garrelts, Kyoungah See, Missy McKean-Matthews, Meghan Feely, Rebecca Bolce, Julie Birt, Vibeke Strand
Journal: Journal of the American Academy of Dermatology (2023)
43335 Ixekizumab reduces IL-17 and IL-23 pathway genes more rapidly than guselkumab: 4-week results from IXORA-R
Authors: Sandra Garcet, Lam C. Tsoi, Andrew Blauvelt, Kim A. Papp, Venkatesh Krishnan, Bruce Konicek, Ernst R. Dow, David Gemperline, Hany Elmaraghy, James Krueger, Johann E. Gudjonsson
Journal: Journal of the American Academy of Dermatology (2023)
41261 Identification of Demographic and Clinical Features Associated with Multi-Biologic Failure in the CorEvitas Psoriasis Registry
Authors: Samuel Yeroushalmi, Angel Cronin, Carla Roberts-Toler, George Gondo, Elizabeth Wallace, Soumya Reddy, George Han, Jessica Kaffenberger, Tina Bhutani, Robert McLean, Wilson Liao
Journal: Journal of the American Academy of Dermatology (2023)
42137 Incidence of herpes zoster among patients with psoriasis in the United States
Authors: David Singer, Philippe Thompson-Leduc, Deepshekhar Gupta, Wendy Y. Cheng, Selvam R. Sendhil, Manasvi Sundar, Ella Hagopian, Mei Sheng Duh, Sara Poston
Journal: Journal of the American Academy of Dermatology (2023)
43008 Effisayil ON, an open-label, long-term extension study of spesolimab treatment in patients with generalized pustular psoriasis: interim results for flare treatment
Authors: Alexander A. Navarini, Hervé Bachelez, Siew Eng Choon, Subang Jaya, A. David Burden, Min Zheng, Akimichi Morita, Yuko Tanaka, Binqi Ye, Christian Thoma, Mark G. Lebwohl
Journal: Journal of the American Academy of Dermatology (2023)
44463 Evaluation of a Dermatology Educational Initiative with a Focus on Skin of Color for Primary Care Residents
Authors: Kavita Darji, Tyler Hooton, Rylee Moody, Griffin McNamara, Jennifer To, Eric Armbrecht, Mallory Abate, Jennifer Fehlman, Dee Anna Glaser, Sofia Chaudhry
Journal: Journal of the American Academy of Dermatology (2023)
41915 Improvements in health-related quality of life and psychological symptoms in patients with severe alopecia areata achieving scalp hair regrowth: results from two randomized controlled trials
Authors: Brittany Craiglow, Yang Won Lee, Sergio Vañó-Galván, Alexander Egeberg, Yves Dutronc, Frederick Durand, Evangeline Pierce, Yuxin Ding, Yun-Fei Chen, Arash Mostaghimi
Journal: Journal of the American Academy of Dermatology (2023)
43504 Increasing Physician Competency Regarding The Veteran Experience: A look at long term eﬀects of military service, standards to qualify for VA healthcare, and factors aﬀecting healthcare engagement
Authors: Julie Boisen, Cecil Staples, Madeeha Drissi, Annika Silfvast-Kaiser, Katherine Fiala
Journal: Journal of the American Academy of Dermatology (2023)
43799 Efficacy and Safety of Upadacitinib in Moderate-to-Severe Hidradenitis Suppurativa: A Phase 2, Randomized, Placebo-Controlled Study
Authors: Alexa B. Kimball, Lindsay Ackerman, Bethanee J. Schlosser, Vimal H. Prajapati, Scott Fretzin, Hidetoshi Takahashi, Tianyu Zhan, Xiaohong Huang, Heidi S. Camp
Journal: Journal of the American Academy of Dermatology (2023)
43751 Efficacy and safety of spesolimab for generalized pustular psoriasis treatment according to flare trigger
Authors: Claudia de la Cruz, Akimichi Morita, Boni Elewski, Kamran Ghoreschi, Binqi Ye, S. Renée Marshall, Christian Thoma, Siew Eng Choon
Journal: Journal of the American Academy of Dermatology (2023)
41766 Efficacy of a Virtual, State-Wide, Dermatology Advocacy Day in Promoting Advocacy Efforts amongst Medical Trainees
Authors: Casey Engel, Sanjoli Agarwal, Landon Hobbs, Glynn Reno, Sarah Alnaif, Ashley Jahad, Iain Noel Encarnation, Madeline Coleman, Katie O'Connell, Olivia Lee, Robert Smith
Journal: Journal of the American Academy of Dermatology (2023)